// App-Quantinova.ai

e19150 : Impact of low molecular weight heparin on overall survival in patients with advanced lung cancer: A retrospective study.

Researchers

Presenter

  • Shuchi Gulati

Principal Investigators

  • Mahender Yellu

  • Neetu Radhakrishnan

  • Nagla Fawzy Abdel Karim

  • Nabeela Iffat Siddiqi

  • Jane M. Pruemer

  • Changchun Xie

Medical Centers

  • University of Cincinatti Medical Center, Cincinatti, OH

  • University of Cincinnati Medical Center, Cincinnati, OHUniversity of Cincinnati, Mason, OHUniversity of Cincinnati Medical Center Biostatistics, Cincinnati, OH

  • University of Cincinnati, Cincinnati, OH

  • University of Cincinnati, Cincinnati, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A